1. Podcast on Lorlatinib as a First-Line Treatment Option for Patients with ALK-Positive Metastatic NSCLC with Brain Metastasis

   • Geoffrey Liu
   • Vincent K. Lam

   Commentary Open access 12 August 2023 Pages: 4117 - 4126

2. Uterine Fibroids: A Podcast on Patient and Physician Perspectives on Medical Management and a New Medical Therapy (Relugolix Combination Therapy)

   • Sateria R. Venable
   • Ayman Al-Hendy

   Commentary Open access 12 August 2023 Pages: 4127 - 4133

3. Avelumab as First-Line Maintenance Treatment in Locally Advanced or Metastatic Urothelial Carcinoma

   • André Mansinho
   • Andreia Cruz
   • Isabel Augusto

   Guidelines 22 August 2023 Pages: 4134 - 4150

   

4. Perspectives and Considerations of IABP in the Era of ECMO for Cardiogenic Shock

   • Zelin Chen
   • Yuping Gao
   • Yuanyuan Lin

   Review 18 July 2023 Pages: 4151 - 4165

   

5. Understanding the Global Burden of Influenza in Adults Aged 18–64 years: A Systematic Literature Review from 2012 to 2022

   • Farzaneh Maleki
   • Verna Welch
   • Isabelle Whittle

   Review Open access 20 July 2023 Pages: 4166 - 4188

   

6. Real-World Outcomes of Trilaciclib Among Patients with Extensive-Stage Small Cell Lung Cancer Receiving Chemotherapy

   • Jerome Goldschmidt
   • Lowell Hart
   • Lucio Gordan

   Review Open access 25 July 2023 Pages: 4189 - 4215

   

7. Cost-Effectiveness of Newer Antidiabetic Drugs as Second-Line Treatment for Type 2 Diabetes: A Systematic Review

   • Jiejin Zhu
   • Ying Zhou
   • Gang Wang

   Review Open access 29 July 2023 Pages: 4216 - 4235

   

8. Implementing an Evidence-Based COPD Hospital Discharge Protocol: A Narrative Review and Expert Recommendations

   • Marc Miravitlles
   • Mohit Bhutani
   • Jane E. Scullion

   Review Open access 04 August 2023 Pages: 4236 - 4263

   

9. Prescription of DOACs in Patients with Atrial Fibrillation at Different Stages of Renal Insufficiency

   • Kai Hahn
   • Mathias Lamparter

   Review Open access 18 August 2023 Pages: 4264 - 4281

   

10. DElaying Disease Progression In COPD with Early Initiation of Dual Bronchodilator or Triple Inhaled PharmacoTherapy (DEPICT): A Predictive Modelling Approach

    • Dave Singh
    • Diego Litewka
    • Peter Daley-Yates

    Original Research Open access 29 June 2023 Pages: 4282 - 4297

    

11. The Cost-Effectiveness of Sugemalimab Plus Chemotherapy as First-Line Treatment for Metastatic Squamous and Non-squamous NSCLC in China

    • Rihua Cheng
    • Zhen Zhou
    • Qiao Liu

    Original Research 15 July 2023 Pages: 4298 - 4309

    

12. Physiologically Based Pharmacokinetic Modeling to Simulate CYP3A4-Mediated Drug-Drug Interactions for Pyrotinib

    • Liang Ni
    • Liang Zheng
    • Xijing Chen

    Original Research 16 July 2023 Pages: 4310 - 4320

    

13. Unmet Needs in Real-World Advanced Therapy-Naïve and -Experienced Patients with Moderately to Severely Active Ulcerative Colitis in the United States

    • Anita Afzali
    • Rina Lukanova
    • Komal Gupte-Singh

    Original Research Open access 17 July 2023 Pages: 4321 - 4338

    

14. An EMT-Related Gene Signature to Predict the Prognosis of Triple-Negative Breast Cancer

    • Bo Zhang
    • Rong Zhao
    • Liang Yao

    Original Research Open access 18 July 2023 Pages: 4339 - 4357

    

15. Treatment Patterns and Healthcare Resource Utilization Among Newly Diagnosed Psoriasis, Psoriatic Arthritis, Axial Spondyloarthritis, and Hidradenitis Suppurativa Patients with Past Diagnosis of an Inflammatory Condition: A Retrospective Cohort Analysis of Claims Data in the United States

    • Sari Hopson
    • Liza R. Gibbs
    • Silky Beaty

    Original Research Open access 24 July 2023 Pages: 4358 - 4376

    

16. People Diagnosed with Myasthenia Gravis have Lower health-related quality of life and Need More Medical and Caregiver Help in Comparison to the General Population: Analysis of Two Observational Studies

    • S. Dewilde
    • G. Phillips
    • M. F. Janssen

    Original Research Open access 25 July 2023 Pages: 4377 - 4394

    

17. Remimazolam Compared to Propofol for Total Intravenous Anesthesia with Remifentanil on the Recovery of Psychomotor Function: A Randomized Controlled Trial

    • Takahito Shimizu
    • Toshifumi Takasusuki
    • Shigeki Yamaguchi

    Original Research Open access 25 July 2023 Pages: 4395 - 4404

    

18. Global Economic Burden Associated with Chronic Kidney Disease: A Pragmatic Review of Medical Costs for the Inside CKD Research Programme

    • Vivekanand Jha
    • Saeed M. G. Al-Ghamdi
    • Juan Jose Garcia Sanchez

    Original Research Open access 26 July 2023 Pages: 4405 - 4420

    

19. Real-World Persistence of Ustekinumab in the Treatment of Inflammatory Bowel Disease

    • Brian Bressler
    • Jennifer Jones
    • John K. Marshall

    Original Research 28 July 2023 Pages: 4421 - 4439

    

20. Modeling of Treatment Outcomes with Tofacitinib Maintenance Therapy in Patients with Ulcerative Colitis: A Post Hoc Analysis of Data from the OCTAVE Clinical Program

    • Michael Chiorean
    • Marco Daperno
    • Roger A. Edwards

    Original Research Open access 31 July 2023 Pages: 4440 - 4459

    

21. The Economic Burden of Adults with Major Depressive Disorder in the United States (2019)

    • Paul Greenberg
    • Abhishek Chitnis
    • Ronald C. Kessler

    Original Research Open access 31 July 2023 Pages: 4460 - 4479

    

22. Healthcare Costs in Men with Metastatic Castration-Resistant Prostate Cancer: An Analysis of US Medicare Fee-For-Service Claims

    • Stephen J. Freedland
    • Matthew R. Davis
    • Jasmina I. Ivanova

    Original Research Open access 02 August 2023 Pages: 4480 - 4492

    

23. One-Year Medication Adherence and Persistence in Rheumatoid Arthritis in Clinical Practice: A Retrospective Analysis of Upadacitinib, Adalimumab, Baricitinib, and Tofacitinib

    • Martin Bergman
    • Naijun Chen
    • Patrick Zueger

    Original Research Open access 05 August 2023 Pages: 4493 - 4503

    

24. Real-World Data of Adherence and Drug Survival of Biologics in Treatment-Naïve and Treatment-experienced Adult Patients with Rheumatoid Arthritis

    • Vered Rosenberg
    • Gabriel Chodick
    • Howard Amital

    Original Research Open access 11 August 2023 Pages: 4504 - 4522

    

25. Unintended Consequences of Increased Out-of-Pocket Costs During Medicare Coverage Gap on Anticoagulant Discontinuation and Stroke

    • Tabassum Salam
    • Urvi Desai
    • Akshay Kharat

    Original Research Open access 11 August 2023 Pages: 4523 - 4544

    

26. Real-World Data About Treatment Outcomes for Patients with EGFR-Mutated NSCLC Resistance to Osimertinib and Platinum-Based Chemotherapy

    • Hidetoshi Hayashi
    • Makoto Nishio
    • Mami Kasahara-Kiritani

    Original Research Open access 12 August 2023 Pages: 4545 - 4560

    

27. Clinical Performance of New Enhanced Monofocal Intraocular Lenses: Comparison of Hydrophobic C-loop and Hydrophilic Plate-Haptic Platform

    • Andreas F. Borkenstein
    • Eva-Maria Borkenstein

    Original Research Open access 16 August 2023 Pages: 4561 - 4573

    

28. Efficacy and Safety of Triptorelin 3-Month Formulation in Chinese Children with Central Precocious Puberty: A Phase 3, Open-Label, Single-Arm Study

    • Xiaoping Luo
    • Cai Zhang
    • Patrick Cabri

    Original Research Open access 16 August 2023 Pages: 4574 - 4588

    

29. Health Care Resource Utilization and Costs for Patients with Spinal Muscular Atrophy: Findings from a Retrospective US Claims Database Analysis

    • Walter Toro
    • Min Yang
    • Omar Dabbous

    Original Research Open access 16 August 2023 Pages: 4589 - 4605

    

30. Understanding the Clinical Implications of Individual Patient Characteristics and Treatment Choice on the Risk of Exacerbation in Asthma Patients with Moderate–Severe Symptoms

    • Dave Singh
    • Sean Oosterholt
    • Oscar Della Pasqua

    Original Research Open access 17 August 2023 Pages: 4606 - 4625

    

31. Post-infusion Costs Associated with Idecabtagene Vicleucel Treatment for Patients with Relapsed/Refractory Multiple Myeloma in the KarMMa Trial

    • November McGarvey
    • Brian Ung
    • Pallavi Patwardhan

    Original Research Open access 19 August 2023 Pages: 4626 - 4638

    

32. Phase 3 Clinical Trial Comparing the Safety and Efficacy of Netarsudil to Ripasudil in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: Japan Rho Kinase Elevated Intraocular Pressure Treatment Trial (J-ROCKET)

    • Makoto Araie
    • Kazuhisa Sugiyama
    • Casey C. Kopczynski

    Original Research Open access 21 August 2023 Pages: 4639 - 4656

    

33. Identifying Predictors of First-Line Subcutaneous TNF-Inhibitor Persistence in Patients with Inflammatory Arthritis: A Decision Tree Analysis by Indication

    • Johan Dalén
    • Axel Svedbom
    • Christopher M. Black

    Original Research Open access 11 August 2023 Pages: 4657 - 4674

    

34. Key Device Attributes for Injectable Somatostatin Receptor Ligand Therapy in Acromegaly and Neuroendocrine Tumours

    • Jens Otto L. Jørgensen
    • Wouter W. de Herder
    • Shlomo Melmed

    Brief Report 12 August 2023 Pages: 4675 - 4688

    

35. Correction to: DElaying Disease Progression In COPD with Early Initiation of Dual Bronchodilator or Triple Inhaled PharmacoTherapy (DEPICT): A Predictive Modelling Approach

    • Dave Singh
    • Diego Litewka
    • Peter Daley-Yates

    Correction Open access 28 July 2023 Pages: 4689 - 4690

    

36. Correction to: Pharyngeal Reconstruction Methods to Reduce the Risk of Pharyngocutaneous Fistula After Primary Total Laryngectomy: A Scoping Review

    • Alvaro Sanabria
    • María Paula Olivera
    • Alfio Ferlito

    Correction Open access 01 August 2023 Pages: 4691 - 4692

37. Correction to: Effect of Nicorandil, Diltiazem, or Isosorbide Mononitrate for Oral Antispastic Therapy After Coronary Artery Bypass Grafting Using Radial Artery Grafts—A Pilot Randomized Controlled Trial (ASRAB-Pilot): Rationale and Study Protocol

    • Yunpeng Zhu
    • Kaijie Qin
    • Qiang Zhao

    Correction 10 August 2023 Pages: 4693 - 4693